Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : Space required after the Public Identifier in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: <!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 2.0//EN"> in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : SystemLiteral " or ' expected in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: <!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 2.0//EN"> in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : SYSTEM or PUBLIC, the URI is missing in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: <!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 2.0//EN"> in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : Space required after the Public Identifier in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: <!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 2.0//EN"> in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : SystemLiteral " or ' expected in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: <!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 2.0//EN"> in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : SYSTEM or PUBLIC, the URI is missing in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: <!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 2.0//EN"> in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /data/home/httpd/shieldedsearch.com/class/class.Ads.php on line 272

Business

 

More videos:

Sorry no items were found for US+BusinessSorry no items were found for US+Celebrity

Wall Street rises after China market steadies
China's top securities regulator said on Monday that Beijing would keep buying shares to stabilize the market, after the steepest decline in Chinese stocks in eight years. Baidu slumped as much as 17.7 percent to $162.72 after China's biggest Internet search company's quarterly profit missed estimates. United Parcel Service rose 5.2 percent to $100.03 after the company's quarterly profit rose.

U.S. consumer mood sours, home price growth stalls
By Richard Leong and Chuck Mikolajczak NEW YORK (Reuters) - U.S. consumer confidence took its biggest tumble in four years in July on a less upbeat jobs outlook, while home appreciation in major cities stalled in May, suggesting a spring pause in housing demand. The disappointing data comes as Federal Reserve policymakers meet to consider whether the U.S. economy is strong enough to warrant an end to the Fed's near zero interest rate policy, perhaps as soon as September. The Federal Open Market Committee, the U.S. central bank's policy-setting group, is meeting on Tuesday and Wednesday.

Honeywell to buy Melroses utility metering business for $5.1 billion
The move, announced on Tuesday, is the first major deal for Honeywell, the U.S. diversified industrial manufacturer, since it laid out a five-year plan in March 2014 to target at least $10 billion in acquisitions. The acquisition will give Honeywell access to Elster Group's metering technology and customers in the highly regulated heating, controls and metering industries, including smart meters and data analytics. Honeywell shares rose nearly 2 percent at $103.61 in mid-day trading, while Melrose was up nearly 10 percent.

Pfizers revenue, profit beat as vaccine sales rise
The unit, which includes the Prevnar 13 pneumonia vaccine, accounted for about 13 percent of Pfizer's total revenue. The breast cancer drug Ibrance, which gained U.S. approval in February, generated $140 million in sales in its first full quarter on the market, nearly double analysts' expectations. Despite years of competition from cheaper generic copies, Pfizer's cholesterol fighter Lipitor contributed sales of $509 million in the second quarter.

After strong quarter, Ford aims to disrupt like a startup
Ford Motor Co's chief executive, Mark Fields, said on Tuesday he wants the company to act "like a startup" as it prepares for an evolution of the auto industry, after it posted second-quarter profit that handily beat expectations. Ford and other major automakers are racing to position themselves to profit during what Fields termed a rare "period of change and disruption in the industry" that includes car-sharing, autonomous vehicles, connected cars and new ways for people to get around. Fields pointed to 25 experiments Ford announced earlier this year to determine mobility needs of the globe's consumers in coming decades.

Denials fly in war of nerves over Greek debt talks
By Renee Maltezou and Francesco Guarascio ATHENS/BRUSSELS (Reuters) - Conflicting statements and denials flew between Athens and Brussels on Tuesday in a war of nerves highlighting the depth of mutual mistrust over a new round of negotiations on an 86 billion euro bailout that started this week. Any hope of a fresh start in fraught relations between Greece's leftist government, purged of its most radical members, and the institutions representing its creditors, appeared to be dashed by the flurry of assertions and rebuttals. Differences included the pace and conduct of bailout talks, whether or not Greece needs to enact further laws before a deal, the reopening of the Athens stock exchange, and the activities of former finance minister Yanis Varoufakis, who continues to heap abuse on the creditors in his blog.

BP profits slump after huge oil spill charge
BP's second-quarter profit slumped by nearly two thirds from last year as it grappled with lower oil prices, a write off in Libya and a $10.8 billion charge for the 2010 crude spill in the Gulf of Mexico. BP's Chief Financial Officer Brian Gilvary said he expected oil prices , which fell on Tuesday to their lowest since February below $53 a barrel, to remain soft in the medium term because of a supply glut worldwide. BP reached an $18.7 billion agreement with the U.S. government and five states earlier this month to resolve most claims from the oil spill five years ago, the largest corporate settlement in U.S. history.

Hikma to buy Boehringers U.S. generics unit for $2.65 billion
(Reuters) - Hikma Pharmaceuticals Plc said it would buy German drugmaker Boehringer Ingelheim's U.S. specialty generic drugs business for about $2.65 billion in cash and stock to bolster its presence in the United States. Hikma said it will pay about $1.18 billion in cash and issue 40 million new Hikma shares, or about 16.71 per cent of its issued share capital, for Boehringer's Roxane Laboratories Inc and Boehringer Ingelheim Roxane Inc on closing of the deal. The Jordanian company, which makes and markets branded and non-branded generics and injectable drugs, said the deal would make it the sixth biggest U.S. generics provider.

Cerberus leads U.S. investors gobbling up Europes bank loans
Cerberus, the private equity firm named after the mythical three-headed dog guarding the gates of Hades, is leading a charge by U.S. investors who are snapping up European loans at knockdown prices. New York-based Cerberus Capital Management [CBS.UL] has bought more than 27 billion euros ($30 billion) of European loans in the last 2-1/2 years, acting along with rivals such as Lone Star and Blackstone to snap up commercial and residential debt from banks desperate to shrink or governments running down so-called "bad banks".

DuPont sees challenging months ahead as farm sales weaken
DuPont also cut its full-year profit forecast due to the weak outlook and to account for the spin-off of its performance chemicals unit, sending its shares down as much as 7 percent to a two-year low. DuPont, whose sales have missed analysts' expectations for the last four quarters, has also been hit by a strengthening dollar. "We fully expect to continue to find additional opportunities that will take us beyond the $1.3 billion of cost reduction," Chief Executive Ellen Kullman said on a post-earnings call on Tuesday.

Dragon Quest XI may be one of the first Nintendo NX games
Its been a long time coming, but another Dragon Quest title is on the way -- and youll want to keep your eye on this one. Square Enix has announced Dragon Quest XI, a solo role-playing game (no DQX-style ...

Indie developers out thousands of dollars in OUYA-Razer deal

High-Priced Trucks Propel Ford
Ford has benefited from consumer appetite for higher-priced trucks and sport-utility vehicles, which propelled the automaker to a record second-quarter profit in North America.

Microsofts Fifth Avenue flagship store will open this fall

Review: Goodbye, Windows 8; hello, Windows 10
Here's my 'non-reviewer's review' of Windows 10 after using it for a week. Spoiler alert: My laptop has gone Windows 10 and isn't going back.